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Abstract
Background: In the United Sates, nearly 1 million people identify as being transgender and 2%
(671) of transgender people were diagnosed with HIV in the U.S. and dependent areas in 2019
(CDC, 2022b). Studies have reported of transgender people avoiding the healthcare setting due
to fear of facing stigma and discrimination. Due to this stigma and discrimination in the
healthcare setting, transgender people may choose not to participate in HIV screening. The
studies also emphasized a lack of LGBTQ+ education in the academic setting. The purpose of
this quality improvement project (QIP) was to improve the knowledge of healthcare
professionals regarding transgender stigma and discrimination in the healthcare setting and how
it affects their willingness to participate in HIV screening in the primary care setting.
Methods: The findings from literature reviews were used in the creation of this QIP. A survey
was created for the pre- and post-intervention. The survey consisted of 12 demographic questions
and 15 knowledge questions on transgender stigma, discrimination, and HIV. Twenty-three
participants completed the pre-survey, and eighteen participants completed the educational
session and post-survey. A 30-minute evidenced-based educational session was conducted at a
primary care clinic on transgender stigma and discrimination in the healthcare setting and how it
affects HIV screening.
Results: There was a 31.05% mean increase from the pre-survey to the post-survey after the 30minute educational session was conducted. The results indicated improvement in the knowledge
question responses after the 30-minute educational session. Knowledge scores from the pre- and
post-surveys were compared which were statistically significant based on the p-value.
Conclusion: These findings indicated that by educating healthcare professionals on transgender
stigma and discrimination in the healthcare setting, it can increase their knowledge and improve
transgender patients experience when seeking medical care.
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Chapter I
Introduction
Problem Statement
Transgender is a term that defines an individual who does not identify with their assigned
sex and associated gender that they were assigned at birth (Kachen & Pharr, 2020). It is
suggested that many transgender individuals experience stigma and discrimination in their dayto-day lives that has affected them in accessing health care (Centers for Disease Control and
Prevention [CDC], 2021c). According to Kelley (2021), when transgender patients go to their
medical appointment, they face stigma, which includes providers’ use of excessive precautions,
being blamed for their health conditions, experiencing physical and verbal abuse, and
encountering complete refusal of care. For example, a transgender female goes to her primary
care provider who is unfamiliar with transgender health. For the duration of the appointment,
instead of addressing the concerns of the patient, the provider much of the time questions the
transgender female’s identity. As the appointment nears its end, the transgender female patient is
finally able to ask about some of her concerns. However, the provider gives the patient a
pamphlet on HIV and tells his patient to find a specialist to take over their care. The result of this
treatment is that this transgender patient leaves not being able to ask about hormone replacement
therapy and the consequences of the untreated chronic abdominal pain she is currently
experiencing (Kelley, 2021). This is one of many incidences that transgender patients face when
trying to get medical care. According to Kachen and Pharr (2020), transgender patients have
experienced reduced access to healthcare, delaying medical care due to fear of discrimination,
higher rates of negative health behaviors, and poorer health outcomes.
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Background
Transgender patients are often treated as having a mental illness and are automatically
presumed to have Human Immunodeficiency Virus (HIV). Most of the time these problems are
unintentional and can be prevented by educating and training healthcare professionals on basic
transgender health. Andrzejewski et al. (2021) conducted a recent meta-analysis study that
included laboratory-confirmed HIV testing estimated an HIV prevalence of 9.2% for all
transgender individuals in the United States, higher prevalence in transgender women. It is
estimated that one in five women who identify as transgender are living with HIV, with more
than double the HIV prevalence among African American transgender females in the United
States (Kalichman et al., 2017). There are many barriers to HIV testing among transgender
patients, that being homelessness, healthcare provider mistreatment, and HIV-related stigmas
(Vaitses Fontanari et al., 2019). There are two preventative methods for HIV: preexposure
prophylaxis (PrEP) and postexposure prophylaxis (PEP). According to the CDC (2020b), PrEP is
a medication that is one pill taken every day at the same time for patients at risk of contracting
HIV. It is suggested that PrEP can reduce the risk of getting HIV by 99% if taken as prescribed
(CDC, 2020b). PEP on the other hand is two medications that must be taken 72 hours post-HIV
suspected exposure that is taken for 30 days (CDC, 2020a). Although there is prevention for
HIV, it is suggested that there are significant barriers for PrEP and PEP access in the transgender
community, which include provider discrimination and cultural incompetency, high cost and
unreliable insurance coverage, mental health comorbidities, and medication side effects (Watson
et al., 2020). Transgender patients also avoid the healthcare setting due to fear of stigma and
discrimination due to their gender identity that at many times some of these individuals may not
be aware of the preventative methods that may keep them from contracting HIV.
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Scope of the Problem
Several health disparities are affecting the transgender community in accessing HIV
screening and prevention. According to Reback et al., (2019) transgender females are exposed to
a range of socio-structural risks including stigma, discrimination, criminalization, violence,
economic insecurity, mental health issues, and sexual risk behaviors that lead to high HIV
incidence and prevalence. It is suggested that HIV prevalence rates among transgender females
are estimated between 22% and 28% nationally, higher than any population (Reback et al.,
2019). Transgender men, on the other hand, have a lower HIV prevalence but it has been
suggested that the risk increases when a trans man has sex with a cisgender male (Andrzejewski
et al., 2021). Cisgender can be defined as an individual who identifies with their assigned sex at
birth (CDC, 2019a). Transgender individuals face unique barriers when wanting to access
healthcare. Transgender patients may experience discrimination related to sexual identity, gender
identity, or sex work-related stigma in the healthcare setting (Brookfield et al., 2020). This
stigma and discrimination in the healthcare setting can discourage a transgender patient from
getting HIV screened which may delay their diagnosis and treatment if they have contracted the
virus (Brookfield et al., 2020). Most of the time this stigma and discrimination is unintentional
and may be due to a lack of knowledge from the healthcare staff. According to Eickhoff (2021),
healthcare professionals shared that they would have wanted better education and training on
LGBTQ health. It was published that only 5 hours of LGBTQ+ education is presented in both the
United States and Canada’s medical education. According to Eickhoff (2021), 18 nursing schools
in their study did not teach material related to LGBTQ+ health, which leaves their students with
cultural congruency deficit that may impact their patient care and experience. This lack of
education in transgender health is affecting healthcare professionals’ interaction with this
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community which is turning away transgender patients from seeking HIV screening and learning
about PrEP and PEP access.
Consequences of the Problem
According to Brookfield et al. (2020), the accessibility of sexual health screening,
counseling, and treatment can be restricted in settings pervaded by stigma, marginalization, and
resource constraints. It is suggested that a person who identifies as transgender experiences a
disproportionately high prevalence of HIV and Sexually Transmitted Infections (STIs) in low-,
middle-, and high-income countries (Brookfield et al., 2020). According to the CDC (2021a),
there are 1 million people that identify as transgender in the United States, and only 601 were
diagnosed with HIV in 2018. It is suggested that the HIV prevalence in the United States has
been estimated to be more than 34 times as high among transgender women compared with all
other people ages 15 to 49 years old (Pitasi et al., 2020). Despite the high prevalence, HIV
testing among the transgender community remains low where one in 10 transgender patients
have been tested in the past year (Pitasi et al., 2020). According to Pitasi et al. (2020), barriers
such as gender-related stigma, discrimination, negative experiences in the healthcare setting, and
lack of culturally competent and gender-affirming care can discourage utilization of care and
routine HIV testing. Many individuals in the trans community rely on sex work as their source of
income (Brookfield et al., 2020). HIV testing provides these patients the opportunity to learn
about HIV prevention and treatment services and can improve HIV prevalence and prevent the
person from contracting HIV (Pitasi et al., 2020). For this reason, healthcare professionals must
be properly educated on transgender health, their risk of contracting HIV, and how stigma and
discrimination play a role in being a barrier in obtaining access to healthcare for this community.
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Knowledge Gaps
Based on the information gathered, healthcare professionals are not trained on
transgender health or how to be culturally sensitive to this population. According to Hana et al.,
(2021), contributors to stigma and discrimination in the transgender population are prejudice,
inadequate medical training, and conscious and unconscious bias among healthcare workers, cisnormative service models that presume all patients, learners, and clinicians are not transgender or
gender diverse. According to Arora et al (2020), healthcare providers have reported a lack of
training which compromises their ability to deliver care to someone that is transgender. It is
suggested that there is minimal to no inclusion of transgender health in medical undergraduate
programs (Hana et al., 2021). According to Hana et al., (2021), the undergraduate educational
environment described by medical students to be more heteronormative and cis-normative.
Postgraduate level programs consist of few studies exploring the impact of one-time
interventions to teach gender-affirming care, which resulted in medical trainees feeling
unprepared or lacking the experience to care for patients that are transgender and gender diverse
(Hana et al., 2021). There needs to be more education on transgender health, gender identity,
learning the different gender terms, and understanding how the stigma and discrimination are a
huge barrier when it comes to healthcare access for the transgender community. This education
is important so that a transgender person feels secure and welcomed whenever they try to seek
medical care.
Proposal Solution
Overall, stigma and discrimination exist within the transgender community. These
problems need to be addressed to reduce these barriers that are affecting the transgender
community in accessing healthcare. Healthcare professionals need to be trained and educated on
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how to properly interact with someone that is transgender. It is important to train healthcare
professionals on how to not offend or embarrass patients when the individual does not identify
with their birth sex. Healthcare professionals should be respectful of the patient's preferred
pronoun without questioning or making the person feel bad. This type of education needs to be
provided to all health care disciplines since each one is involved with the care of the transgender
patient the moment that the individual steps foot in the healthcare setting. The purpose of this
quality improvement project is to improve health care professionals on transgender stigma and
discrimination in the healthcare setting and how it affects their willingness to participate in HIV
screening.
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Chapter II
Summary of the Literature
The term transgender is an umbrella term for populations whose gender identity does not
fall into a traditional cisgender category or differs from the one assigned at birth. Despite high
rates of HIV prevalence, close to 50% of transgender people are unaware of their HIV status
(Centers for Disease Control and Prevention [CDC], 2021b). Hence, HIV screening is a vital step
in limiting the spread of the virus and starting timely treatment. According to Healthy People
2030 (n. d.), in order to end the HIV epidemic, the healthcare system should strive to achieve a
90% decrease in new HIV cases by 2030 by implementing four key strategies, such as prevent,
diagnose, treat, and respond. Leite et al. (2021) pointed out that the most important strategy to
contain the spread of the virus is to inform people about their HIV status. The model of
healthcare aimed at transgender adults and adolescents, as an at-risk population, includes a
combination of such services as prevention practices (condoms, PEP, PrEP, and lubricants),
regular screening, continued care, and treatment (Leite et al., 2021). Thus, the main purpose is
creating and maintaining a trust-based bond between the transgender community and healthcare
professionals, so the latter could provide healthcare services, monitor, and promote health
education. At the same time, such services are not always accessible for trans people. Because of
structural, personal, and interpersonal stigma, transgender people have inadequate access to
healthcare services and HIV information (Jadwin-Cakmak et al., 2021; Sundus et al., 2021).
Studies suggested that discrimination at healthcare facilities is one of the most significant
barriers preventing the at-risk population from regular testing and visiting their healthcare
providers (Leite et al., 2021; Poteat et al., 2017). Due to the vulnerability of the concerned
population to HIV infection, it is imperative for healthcare providers to promote HIV testing
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among trans individuals. The present paper aims at researching how stigma and discrimination
affects a transgender persons access to care and how it affects HIV screening.
Search Strategies
Search strategies of the paper aimed at locating credible sources that discussed culturally
sensitive approaches in the context of HIV prevention programs among the transgender
community. In order to reach the objective, 15 sources were analyzed and synthesized into a
literature review. The search of relevant information was conducted in the databases of PubMed,
CINAHL, and CDC following a set of specific criteria. First, the data had to be up to date,
published within the interval from 2017 up to 2022. Second, the publisher had to be a peerreviewed and scholarly journal or relevant information from an official institute’s portal. Third,
the sources are dedicated to studying the transgender population from different perspectives of
the healthcare continuum. The keywords in the search process included transgender population,
LGBTQ, transgender stigma and discrimination, HIV testing, stigma, HIV education, and HIV
interventions. As databases pulled over 1,000 results with the indexed words, the second stage of
the search strategy involved manual selection. Consequently, 15 sources were deemed as the
most consistent with the topic under discussion and were chosen for further analysis. After due
processing and categorizing, the information that met the selection criteria was summarized in
the sub-themes discussed below.
Definition of Transgender Community
In order to examine the problem of HIV prevention strategies in the transgender
population, it is necessary to draw the definition of the transgender community and understand
the composition of the transgender group. Thus, according to Poteat et al. (2017), the term
transgender population denotes a social group with a different gender identity from the one at
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birth. Usually, gender identity defined at birth is identified by the look of the external genitalia
and mentioned in the birth certificate. Gender or gender identity has been defined and described
by a large number of sources. In general terms, gender can be described as the characteristics of
men, boys, women, and girls that are constructed by society. The problem of the high rates of
HIV in transgender people is especially important given the size of the community. According to
Poteat et al. (2017), recent data indicates that more than 25 million of the global population are
transgender. In the United States, statistics from thirty states show that close to 1.4 million
Americans consider themselves transgender. Notably, according to Mueller et al. (2017),
healthcare inquiry into the transgender community has become a focus of scientific attention
only recently. At the same time, transgender men and women are becoming increasingly visible
not only as part of artistic circles but academic leadership.
Prevalence of HIV in the Transgender Community
Transgender populations are disproportionately impacted by HIV. To estimate the
prevalence, CDC (2019b) conducted a meta-analysis of studies concerning HIV rates in the
transgender community, stating that transgender females can be considered one of the most
highly affected by HIV in the United States. Particularly, HIV prevalence reached 14.1% in
women who identify themselves as transgender, compared to 3.2% in men (CDC, 2019b). The
prevalence is especially elevated among transgender women of color. According to JadwinCakmak et al. (2019), self-reported rates of HIV in African American adult women are close to
20%, and 4% are attributable to Latina transgender women. Due to the high rates of HIV
prevalence, the majority of studies were dedicated to researching the transgender women
population. However, most recently, the focus had shifted to studying transgender men,
especially those who have sex with other men (Fisher et al., 2018; Jadwin-Cakmak et al., 2018;
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Reback et al., 2018). As for the general prevalence, 9.2% of the overall transgender community
in the country was diagnosed with HIV (Andrzejewski et al., 2021). To compare, HIV rates in
the general population constitute less than 0.5% (CDC, 2019b). These alarming statistics confirm
the existence of health disparities in the transgender community and highlight the need to
develop effective strategies to address the problem.
Vulnerability to HIV
Regardless of the HIV status, members of the transgender community have diverse
structural, social, interpersonal, and personal determinants that contribute to the high prevalence
of HIV, though not all of them are purely transgender-specific. Interpersonal and personal
variables include unsafe sexual practices, such as intercourse without condoms, multiple sex
partners, frequent change of partners, and previous sexually transmitted infections (Mueller et
al., 2017). Additionally, sharing syringes for drugs, hormones, or silicone injections are
considered personal factors contributing to increased rates of HIV in the population. Substance
abuse usually accompanies risky behaviors since it leads to sex under the influence of drugs or
alcohol. Finally, psychological factors of anxiety and depression are in the range of personal
factors.
Interpersonal and personal factors affect transgender women more than men. However,
according to Mueller et al. (2017), although the rates of HIV in transgender men are low, they
must not be neglected. Overall interpersonal variables include sexual assaults (64%), lack of
social support (57%), and physical violence (61%) (Neumann et al., 2017). Thus, transgender
people face discrimination and violence, which are the main interpersonal factors.
On the social and structural levels, transgender adults and adolescents face more issues
than their cisgender counterparts. As per Neumann et al. (2017), structural and social
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determinants putting pressure on the transgender community is unemployment (66% among
transgender women), discrimination (63% overall), and homelessness (57% of transgender
women). Stress can be amplified by other socio-economic determinants related to race, ethnicity,
socio-economic status, and gender. The wellbeing and health of transgender people are
substantially affected by these determinants, which is why a transgender-sensitive strategy is
required for efficient healthcare delivery.
Mainly, high rates of HIV are attributed to risky sexual behaviors. The reason may reside
in the transphobia, discrimination, and the high costs of gender reassignment surgeries that make
transgender people engage in commercial sex with people that pay higher for unprotected sex
(Neumann et al., 2017). As for transgender men, they engage in unprotected sex to affirm their
gender identity and to make money to pay for gender reassignment procedures (Mueller et al.,
2017). Male transgender individuals who did not socialize with the gay community could not
acknowledge how to discuss safe sex practices with their male partners, who have sex with other
men. As per Neumann et al. (2017), transgender men who undergo testosterone therapy may
experience elevated sex drive and vaginal dryness, thus increasing the risk of acquiring
infections including HIV. Finally, both genders may forgo using protection during sexual
intercourse with their primary partners to affirm gender identity.
Drug and substance abuse aggravate the risks of acquiring HIV since it makes
transgender individuals extremely vulnerable to infection. Thus, the discussed population may
acquire and spread HIV by sharing syringes to inject drugs, silicone, and hormones. At the same
time, as per Neumann et al. (2017), transgender people are at a higher risk for acquiring HIV
through sexual contact with a partner who injects drugs through used syringes. Generally, the
use of drugs and alcohol is widespread in this group since they help to cope with social stress and
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hardships. However, the substances make people vulnerable by undermining the will and
capability to discuss safe sex practices with their partners.
Apart from the possibility of being infected through unsafe sexual practices, transgender
people can acquire HIV from sharing syringes to inject hormones, silicone, or drugs. At the same
time, Neumann et al. (2017) note that transgender people have more chances to become infected
with HIV through intercourse with a drug addict who uses injectable substances. Marijuana and
alcohol may be perceived by the transgender community as beneficial options since they help to
relieve stress and anxiety, while decreasing the psychological effects of gender dysphoria,
stigma, and helping to cope with sex work. However, the negative effects of using drugs are
significant as being high or drunk substantially reduces the ability and the will of a person to
negotiate safe sexual practices.
Although the topic of HIV is widely discussed in scientific discourse related to the
transgender community, it is not the only public health problem in the population. Other
important issues include transphobia-related physical abuse, verbal abuse, homicide, depression,
anxiety, suicidal ideation, other mental health issues, and socioeconomic marginalization. Most
importantly, transgender adults and adolescents have unsatisfied healthcare needs due to
unavailable healthcare services and previous negative experiences during the visits.
Psychological concerns may add to preexisting causes of risky behaviors and external
determinants. Brennan et al. (2012) conducted a study on 151 transgender individuals, who
provided commercial sex, were incarcerated or were homeless, to identify whether syndetic
factors contribute to HIV risks. According to Brennan et al. (2012), the psychological conditions
indicate comorbid epidemics that may amplify and co-exist with each other, thus calling for
bundling HIV prevention services to an obligatory healthcare package. The researchers note that
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the bundled services should be cost-effective in order to be accepted by the transgender
community. Such programs would help to nurture resiliency among the indicated population by
integrating supportive strategies into healthcare delivery practices and providing healthy role
models. The education approaches may include instilling beliefs that everyone has the right to
define their identity, that gender diversity is natural, learning to take strength in surviving
negative experiences, and communication with supportive people.
Interventions to Limit the Spread of HIV in the Transgender Community
In the literature review, major efforts in containing the HIV epidemic in the transgender
population are dedicated to limiting the spread of the infection. Poteat et al. (2021) divided the
prevention strategies as behavioral (HIV testing), biomedical (PEP and PrEP), and structural
(transgender-sensitive care).
HIV Testing
HIV screening is a necessary measure both for those who have HIV to access further
interventions and for those who do not have it to start a risk-reduction approaches and other
treatments. According to CDC (2021b), 40% of new HIV cases are attributed to individuals who
do not know that they have the virus. Consequently, the CDC (2021b) recommends all people
aged from 13 to 64 to test for HIV at least once, while at-risk categories of populations are
advised to take a test at least once a year. It is advisable for sexually active women who identify
themselves as trans and men who have sex with men (MSM) to take the test at least once in 3 to
6 months. For people who remain undiagnosed, HIV screening is the first step in starting healthy
lifestyle and preventing the spread of HIV.
HIV testing is critical in limiting the spread of viral infections. In 2015, the National
Institute of Health initiated a clinical trial according to the results of which improved patient
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outcomes are associated with starting antiretroviral (ART) treatment early and getting HIV tested
as soon as possible (CDC, 2021b). A more recent study conducted in Ethiopia is in line with
these findings (Ahmed et al., 2020). The researchers compared the effectiveness of ART in two
groups: one group received therapy at the same day of being tested HIV-positive, while the other
group received medications after 7 days following the diagnosis. Results revealed that the rate of
care retention among the test group was lower, confirming the previous evidence about personal
advantages of early testing. Thus, both studies suggest that early and regular HIV testing can
lead to improved outcomes for HIV-positive people, while people tested negative can have a
chance to re-consider their decisions about sex and drug use. Transgender community being an
at-risk group can be offered prevention treatments, such as PrEP and PEP.
Currently, three types of HIV tests are commonly practiced in the United States.
Although each of the tests provides accurate data, neither can detect the virus immediately after
exposure. According to the CDC (2021b), the nucleic acid tests are very expensive, as they
detect the actual virus in the bloodstream within 10 to 33 days. They are recommended for
individuals who had a high-risk contact with the virus as opposed to other methods that are used
in most cases. The second test type can detect antibodies and p24 antigens within 18 to 45 days
after exposure. Antibody tests are the third type of HIV-testing that can be performed on a blood
sample or oral fluids. It detects antibodies in blood and take up from 23 to 90 days. The CDC
(2021b) recommends administering antibody/antigen or antibody testing as an initial test. Follow
up tests are performed in case of positive results from rapid tests. Thus, HIV testing provides
accurate results reducing the chance of missing the diagnosis.

21
PrEP and PEP
One of the current biomedical preventative interventions to combat the high prevalence
rates of HIV in the population is PrEP (pre-exposure prophylaxis). According to CDC (2021b),
PrEP shows almost 99% of effectiveness if taken regularly. Given the incidence rates in
transgender women and MSM, CDC (2021b) suggested linking these populations to PrEP
treatment in their other report. The same report suggested that there are no found drug
interactions between PrEP and hormone therapy medications. This is an important information,
given that most of transgender people take anti-androgen and estrogen drugs. In addition, the pill
should be taken at the same time once per day, which altogether implies that the drug is safe and
convenient for transgender users. However, another study by Reback et al. (2019) suggested that
transgender women and MSM have very low PrEP uptake and adherence rates. The researchers
assume that one of the most probable reasons resides in stigma-related experiences of
transgender people that prevented them from getting HIV tests and accessing proper care
information about PrEP medication.
In case of a suspected HIV-exposure event, healthcare providers may advise transgender
people to take PEP (post-exposure prophylaxis). According to CDC (2020a), PEP prevents the
HIV virus from making copies of itself to circulate through the body. The medication consists of
2-3 pills to be taken for 28 days. However, PEP can be effective only within 72 hours and does
not offer 100% effectiveness. To verify their HIV status, exposed individuals may need to come
for a follow up visit on 4-6 weeks, 3 months, and 6 months after the incident (CDC, 2021b).
However, given that PEP is not fully effective, it could be advised as an emergency measure in
uncommon situations.
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Stigma and Discrimination in Transgender Population
Despite the personal advantages of being tested early in HIV, transgender population are
reluctant to visit healthcare providers. Researchers suggested that the most probable reason of
HIV test avoidance is stigma and discrimination aimed at trans people (Eickhoff, 2021; Fisher et
al., 2018; Jadwin-Cakmak et al., 2019). In a meta-analysis study, Jadwin-Cakmak et al. (2019)
categorized stigma experiences as personal, interpersonal, and structural. On the structural level,
society has propensity for gender stereotyping. If people want to change the sex they were
assigned at birth, they are considered disordered by the society members. Structural stigma can
be observed in healthcare policies and insurance plans limiting access to proper healthcare
services for the transgender population. Many trans people are uninsured or unemployed as a
consequence of employment discrimination, but even if they have insurance, gender affirming
treatments are often considered unnecessary or pre-existing and do not get insurance coverage
(Jadwin-Cakmak et al., 2019).
Failure of national institutions to provide adequate access to healthcare can be seen as a
separate form of structural stigma. According to Jadwin-Cakmak et al. (2019), due to the
inability of medical universities and schools to train future healthcare providers in transgender
care, there is a deficit of competent staff that could address transgender issues. According to a
systematic review by Eickhoff (2021), healthcare practitioners reported that they would like to
receive more detailed education and training on the health issues in LGBTQ+ populations. The
study revealed that future healthcare specialists receive only five hours of education on the
subject in medical institutions both in the United States and in Canada. As per Eickhoff (2021),
the situation with nursing schools is even worse, as 18 schools do not train nurses regarding
transgender health, which results in graduates and newly hired nurses lacking cultural
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information related to the population’s health. Although qualitative research suggested that the
acts of stigma are unintentional and signifies insufficient understanding of the transgender
community, negative experiences cause psychological distress in the transgender community
(Eickhoff, 2021). This fear of stigma from healthcare providers causes a transgender person to
avoid and postpone visiting hospitals and HIV-test centers, which results in negative outcomes
described earlier. Although unintentional, this deficit of cultural sensitivity negatively affects
patient satisfaction and quality of care. Thus, the lack of education hinders successful
communication with the transgender community and prevents its members from seeking HIV
testing and accessing information about PrEP and PEP access.
Social beliefs may reflect stigma on the interpersonal level. According to Logie et al.
(2017), transgender individuals, who did not have gender affirming interventions and whose
stigma is visible to the general population, are often subject to physical and sexual violence.
Notably, the study suggested that transgender people whose signs of gender change are less
visible to others may have even higher level of discrimination once the gender identity becomes
known. This statement may explain the reluctance of transgender individuals in visiting
healthcare organizations, as some may have faced prior bureaucratic obstacles in obtaining
identification documents. Logie et al. (2017) reported instances whereby a transgender individual
going by feminine names are called out by the name they had in their IDs, which raised explicit
and implicit negativity from the people in the waiting lines. It was also reported that close to 30
percent of trans individuals had experienced harassment and discrimination in the medical
settings (Logie et al., 2017). Stigmatized opinions are expressed explicitly when a healthcare
provider is opposed consciously to transgender people or implicitly through the use of a wrong
pronoun or using an outdated terminology when referring to a patient. Interpersonal stigma in
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healthcare has implications for behavior and health of the transgender population, leading to
adverse outcomes for patients and their partners.
Individual-level stigma affects a transgender individual’s perception of themselves and
other people. According to Logie (2017), expecting rejection, trans population may start to avoid
interactions with cisgender people. This coping mechanism leads to the postponed necessary care
and more negative outcomes for trans patients. Internalized stigma may develop into mental
health problems and problematic behavior, which may heighten the risks of contracting STDs
and HIV. Thus, internal stereotyping resembles a loop in which affected individuals do not seek
healthcare due to internalized problems because of being subject to their own stigma.
Gender Dysphoria
The transgender population encounters psychological issues that take the form of gender
dysphoria. According to Mueller et al. (2017), gender dysphoria denotes the distress experienced
by an individual understanding that his or her gender identity differs from the one defined at
birth. In terms of transgender psychology, studies confirm substantial progress in identifying the
needs of the population that chooses to shift to their preferred gender identity (Mueller et al.,
2017; Poteat et al., 2017). The number of people that decided to undergo gender reassignment
procedures has increased since 2000 all around the world significantly. However, both before the
transition and after it, studies note mental health concerns in the transgender population. Apart
from the most frequent problems that include anxiety and depression, recent studies have
detected autistic symptoms among the transgender population. In particular, close to 40% of
transgender individuals have, at least, one episode of suicidal ideation, while the number of
individuals hospitalized after self-harm actions is significantly higher than in the general
population (Mueller et al., 2017). Thus, psychological concerns may represent a barrier in
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accessing adequate healthcare and HIV prevention programs. In this context, social support can
be considered a protective factor against depression and suicidal thoughts in the indicated
population. According to Mueller et al. (2017), post-transition attractiveness, social attitudes, and
acceptance have a great influence on the psychological well-being of a transgender person.
Therefore, healthcare professionals should consider these individual factors when assessing a
transgender patient.
Culturally Sensitive Approach in Educating Transgender People
Transgender populations face discriminatory treatment and stigma-related experiences in
the healthcare settings. To decrease the HIV incidence and prevalence in the population,
healthcare providers should build an ethically competent and informative dialogue with the
transgender community. Thus, the transgender individual should receive relevant and focused
information on the benefits of HIV testing and the availability of PrEP and PEP medications as
the prevention measures. According to Reback et al. (2019), researchers were able to ensure the
linkage of transgender people to PrEP medication by providing quality and relevant information
to the study participants. By eliminating a knowledge gap, it is possible to increase HIV
awareness and encourage to seek HIV testing among the trans people.
In addition to the information itself, it is important to monitor how this information is
communicated. According to Sundus et al. (2021), providers who built trust-based and positive
relationships with their transgender patients were able to achieve increased adherence to medical
recommendations. The opposite is also true, as culturally incompetent care may result in
patients’ avoidance and postponed care. Thus, to limit the spread of HIV in the country by
unaware transgender population, the problem of unethical treatment in the healthcare settings
should be resolved on the national level. Healthcare providers should be knowledgeable about
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transgender health and understand how to deliver the information in a culturally competent way.
According to Sundus et al. (2021), trust-based relationships can be created only if a healthcare
provider knows to avoid offending transgender patients or making them feel awkward by using
the wrong pronoun as opposed to the one a patient expressed their preference for. Leite et al.
(2021) confirmed the positive role of a culturally competent physician in HIV prevention
strategies when dealing with transgender persons. Overall, being professional implies exhibiting
respectful and ethical behavior towards all patients; this is important for the transgender
community.
The transgender population is at risk for HIV infection and unaware spread. Transgender
people are vulnerable to HIV due to a range of personal, interpersonal, social, and structural
factors. First, transgender individuals often fall victim to their own risky behavior, such as unsafe
sexual practices and sharing syringes to inject drugs, hormones, or silicone. Second, transgender
people are subject to physical violence and sexual assaults by the cisgender population. Social
and structural stressors amplify the personal and interpersonal issues albeit in an indirect way.
Financial hardships and psychological issues that are formed by cisgender transphobia contribute
to the high prevalence of HIV in this group since transgender people engage in unsafe
commercial sex for better payment and start using drugs to cope with mental issues.
Consequently, the population under discussion is often subject to stigma and discrimination,
which may prevent such individuals from seeking HIV testing and learning information about
prevention strategies. Stigma in healthcare settings may be intentional or unintentional, though it
negatively affects patient outcomes and HIV-related risks, as it results in the avoidance and
postpones the necessary treatment. In order to increase the transgender community’s engagement
in the efforts to stop the spread of HIV, healthcare professionals should adopt an ethically
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competent education approach towards their non-binary patients. Thus, improving transgender
patients access to care and the quality of care provided by healthcare providers.
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Chapter III
Purpose/PICO Clinical Questions/Objective
Purpose
The purpose of this quality improvement project is to improve healthcare professionals’
knowledge on stigma and discrimination in the transgender community in the healthcare setting
and how it affects their willingness to participate in HIV screening. According to the CDC
(2022a), this stigma and discrimination in the healthcare setting have turned transgender patients
away from getting medical services such as HIV screening. Transgender individuals may put
themselves more at risk in contracting HIV due to certain behaviors. For example, a transgender
person may engage in commercial sex with people that pay more for unprotected sex for money
since jobs tend to turn these individuals away due to their transgender identity (Neumann et al.,
2017). In the United States, transgender women are the most affected by HIV and the prevalence
for HIV has reached 14.1% compared to transgender males (CDC, 2021b). For HIV, there is
preventative methods such as preexposure prophylaxis (PrEP) and postexposure prophylaxis
(PEP). Even though these preventative measures exist, transgender individuals may not be aware
of PrEP and PEP because most transgender people avoid going to healthcare settings due to fear
of stigma and discrimination. In efforts to make healthcare professionals aware of the stigma and
discrimination that the transgender community faces in the healthcare setting, it is imperative to
educate the healthcare providers on this matter and why it is important to screen transgender
patients for HIV and provide PrEP/PEP education.
According to the Centers for Disease Control and Prevention (CDC, 2022b), Florida is
one of the top 10 states with newly HIV infections in 2019. It is suggested that there were 4,378
newly diagnosed HIV infections in Florida (CDC, 2022b). The Florida Department of Health
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(2021) reported 20,507 persons with an HIV diagnosis living in Broward County at the year-end
of 2019. A total of 624 individuals received an HIV diagnosis, and 291 people received an AIDS
diagnosis in Broward County in 2019 (Florida Department of Health [FDOH], 2021). It
suggested that in 2019 people who received an HIV diagnosis in Broward County by mode of
HIV exposure included 1% of the transgender community (FDOH, 2021).
Based on the research conducted thus far, transgender people avoid the healthcare setting
due to fear of discrimination and stigma by healthcare providers (Kelley, 2021). Due to this fear
of stigma and discrimination, transgender people may avoid the healthcare setting and may not
get HIV tested nor be able to learn about the preventative measures for HIV such as preexposure
prophylaxis (PrEP) and postexposure prophylaxis (PEP). Many times, this stigma is
unintentional, and it comes from lack of education. It is important to make healthcare clinicians
aware of why transgender people need to be screened for HIV and understand how stigma and
discrimination plays a role when accessing care.
The purpose of this quality improvement project was to improve the knowledge of
healthcare providers on how stigma and discrimination in the healthcare setting affects the
transgender community from getting screened for the Human Immunodeficiency Virus (HIV).
This QI project was conducted at an outpatient primary care clinic. The outpatient clinic is in the
Broward County area. The clinic serves the surrounding areas of the Fort Lauderdale
community. The clinic participates in research studies and treatments of all chronic conditions
one of them being HIV. The office also offers healthcare assistance coverage which helps
patients with obtaining healthcare access. The office focuses on LGBTQ+ primary care, and HIV
care.
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PICO Clinical Question
The PICO question is as follow: Does an educational session improve healthcare
professionals’ knowledge on how transgender stigma and discrimination in the healthcare setting
affects their participation in HIV screening?
Objectives
The primary objective of this quality improvement project is to improve healthcare
providers’ knowledge on transgender stigma and discrimination in the healthcare setting and its
impact on HIV screening.
SWOT Analysis
A Strength, Weakness, and Opportunities, and Threats (SWOT) analysis was used to assist
with the management of this quality improvement project.
Strengths
Strengths of the organization include serving the LGBTQ+ population. The clinic is in an
area where there are high numbers of HIV infections. The clinic is a research/teaching facility
that welcomes medical students, physician assistant, and nurse practitioner students. The
outpatient clinic is open to new strategies on how to better care for the transgender population.
The clinic staff is approachable, friendly, welcoming, and open to learning. The clinical
administrative team supports new evidence base practice and were very supportive of conducting
the DNP intervention in the clinic. The clinic offers services to approximately 250 transgender
patients.
Weaknesses
Weaknesses of the organization includes the amount of work that the staff does in their
day-to-day role may impede them from completing the pre- and post-survey and not being able
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to attend the educational session. Each provider sees close to 20 to 25 patients per day. There are
nine providers and each member of the healthcare team in the clinic oversees completing the
orders of the providers depending on who they are assigned to. On a very busy day, the
participants may not be able to complete the pre- and post-survey nor attend the educational
session on time.
Opportunities
Opportunities for this study include educating the healthcare staff at the clinic about the
stigma and discrimination that the transgender community faces in the healthcare setting. The
staff learned about the different gender terms that exist today and how to ask a transgender
person their prefer pronoun while being respectful. The educational presentation assisted in
bringing awareness to the healthcare team about the stigma and discrimination that the
transgender community faces in the medical setting and how this pushes this community away
from seeking medical services. This educational session offered participants an opportunity to
learn more on HIV screening and the importance to screen this population.
Threat
Possible threats included potential participants not completing the pre-survey before
educational session or forgetting to complete pre-survey. Another threat was not having enough
participants to attend the educational session. Depending on the date of the educational session,
if it is a busy day, there might not be many participants attending the educational session.

SWOT Analysis of the Outpatient LGBTQ+ Clinic
Strengths
•

The clinic conducts research and is
open to new evidence base practice.

Weaknesses
•

Healthcare staff’s daily
routine/workload may hinder them
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•
•

from completing pre- and postThe clinic is a teaching facility.
survey.
The clinic cares for approximately 250
transgender patients.
• The clinic staff is very welcoming.
Opportunities
Threats
•

•

•

•

The healthcare staff will be more
aware of the stigma and discrimination
that the transgender community faces
in the healthcare setting.
Better understanding about the
importance of HIV screening in the
transgender community.
How stigma and discrimination affect
a transgender person willingness to
participate in HIV screening.
Participants were educated on how to
address someone who’s gender
identity does not match their birth sex.

•

•

Not completing pre-survey and postsurvey on time or forgetting to
complete it before educational session.
Participants not attending educational
session due to that day being a busy
day.
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Chapter IV
Definition of Terms
The following definition of terms for this QI project include cisgender, discrimination,
HIV, nonbinary, PEP, PrEP, stigma, transgender, trans female, and trans male.
1. Cisgender is a person whose current gender identity is the same as their assigned birth
sex (CDC, 2019a).
2. Discrimination can be defined as denying social acceptance that at times may threaten
the individual’s safety (Drabish & Theeke, 2022).
3. HIV (human immunodeficiency virus) is a virus that weakens a patient’s immune
system by destroying immune cells known as CD4 helper t-cells, which help in fighting
diseases and infections (CDC, 2021b).
4. Nonbinary is a person who identifies outside the gender binary of male or female or may
go back and forth between different gender identities (CDC, 2019a).
5. PEP (post-exposure prophylaxis) is a medication that needs to be started with 72 hours
of possible HIV exposure (CDC, 2020a).
6. PrEP (pre-exposure prophylaxis) is a one pill a day medication that needs to be taken
every day at the same time to prevent HIV (CDC, 2020b).
7. Stigma is the social of labeling, stereotyping, and rejecting human difference as a form of
social control (White Hughto et al., 2015).
8. Transgender is a term used for a person whose gender identity is different from their
birth sex (CDC, 2019a).
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9. Trans female Also known as trans women, a trans female is a transfeminine person, or
women of transgender experience, and are women who were assigned male sex at birth
(CDC, 2021c).
10. Trans male Also known as trans men, a trans male is a transmasculine persons, or men
of transgender experience, and are men who were assigned female sex at birth (CDC,
2021c)
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Chapter V
Conceptual Underpinning and Theoretical Framework of the Project
Syndemic Theory
According to Tsai (2018), the theory of syndemics was first proposed by Singer in 1996.
Syndemics can be described as a cluster of certain psychosocial problems, social stigmatization
or disease among marginalized populations and their synergistic effect on increasing a negative
outcome (Chakrapani et al., 2019). The syndemic theory was chosen to frame the development
of this QI project. The psychosocial is the social and cultural discrimination, social
stigmatization, and HIV. The stigma and discrimination that the transgender population faces in
the healthcare setting turns these patients away from seeking medical care. By not seeking
medical care, a transgender person may not get screened for HIV and will pass on the virus
without knowing their HIV status nor finding out of preventative methods such as PrEP and PEP.
Figure 1
Syndemic Theory Diagram

Social and
Cultural
Discrimination

Social
Stigmatization

HIV Infection
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Chapter VI
Methodology
Study Design
This quality improvement (QI) project evaluated healthcare professionals’ knowledge on
transgender stigma and discrimination in the healthcare setting and how it impacts their
willingness to participate in HIV screening. Evidence-based literature was used in the creation of
the surveys and educational presentation. The pre-and post-survey contained 12 demographic
questions that ask participants their gender, birth sex, prefer pronoun, level of education, job
title, if they received LGBTQ+ education, and if so, how long was it and at where was this
education provided. The knowledge section contained 15 questions that were based on the
literature review articles used for this QI project. Participation of this quality improvement
project was voluntary, and the data collected was kept confidential password protected. The
email link provided information on the purpose of the QI project, informational, and recruitment
letter that informed potential participants that completion of the pre-survey questionnaire means
that they are consenting to participating in the QI project.
Setting
This QI project was conducted at an outpatient primary care clinic. The clinic offers
LGBTQ+ care, STD screening services such as STD testing and treatment, HIV care, and
primary care. The clinic offers care to over 250 transgender patients. The clinic provides
hormone replacement therapy, links patients to PrEP/PEP, and helps patient find transgender
support groups. The office also participates in research studies and treatments of all chronic
conditions one of them being HIV.
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Sample
An email invitation was sent to the administrator of the primary care clinic to forward to
all the healthcare staff in the clinic. The healthcare staff includes phlebotomist patient care
coordinators, pharmacist, pharmacy technicians, nurse practitioners, physician associates,
medical doctors, and linkage team. All potential participants either provide care to transgender
patients or their daily job provides regular interaction with the transgender community.
Intervention
An evidence-based educational session was delivered by the DNP candidate in a
classroom style setting. The DNP candidate developed an educational PowerPoint presentation
for the participants. The presentation contained graphics, text, and charts. Literature review
articles was used for the creation of this educational presentation. The educational presentation
contained information on gender identity, sexual orientation, transgender stigma and
discrimination in the healthcare setting, importance of HIV screening, pronouns education, and
proper communication strategies. The educational PowerPoint was delivered as a 20- to 30minute educational session.
The immersion site administrator and DNP candidate picked the date and time for the
educational session. The educational session was conducted in-person as requested by the
immersion site administrator. The educational session was conducted in the main office
conference room during the staffs’ lunch break. Two weeks prior to the educational session, the
DNP candidate sent an email to the immersion site administrator containing the pre-survey link,
date to educational session, recruitment letter (Appendix C), and informational letter (Appendix
D) to forward to the healthcare staff. Two days after the educational session, the DNP candidate
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emailed the office administrator the post-survey link to forward to the staff so that those that
attended the educational presentation could complete the post-survey.
Instruments
The pre- and post-survey was created using Qualtrics. Qualtrics is a survey system
provided by the DNP candidate academic institution. Qualtrics allowed for the survey responses
to stay anonymize, respondents’ IP address, location data, and contact info was not recorded. The
demographic section included questions about the participants’ gender identity, birth sex,
preferred pronoun, sexual orientation, age, highest level of education, job title, length of time
they have worked in the medical field, if they have received LGBTQ+/transgender education
before, and if so for how long and where that education was received.
The knowledge questions were developed by the DNP candidate. Evidence-based
literature review articles were used for the creation of all the surveys knowledge questions. The
first three knowledge question asked participants if they knew the meaning of the following
terms: gender identity, nonbinary, transgender. The next set of questions focused on HIV
statistics in the transgender community, and variables affecting a transgender person from
contracting HIV. There were two true or false questions and the last few questions focused on
communication strategies when interreacting with a transgender person. The surveys were scored
by the DNP candidate and Qualtrics.
Data Collection Procedure
The initial email was sent to the immersion site administrator to forward it to the staff.
The initial email contained the recruitment letter (Appendix C), informational letter (Appendix
D), date of the educational session, and the purpose of this QI project. Potential participants were
informed in the email that by completing pre-survey questionnaire it means they are consenting
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to participating in this QI project. Recruitment occurred via email and in person, the DNP
candidate gave out flyers containing the information of the informational letter and a QR code
that gave the healthcare staff access to completing the pre-survey questionnaire. The participants
were made aware that there is no monetary incentive for participating in this QI project via email
and in person.
The healthcare staff was given 2 weeks to complete the pre-survey questionnaire.
Reminders were sent out every week. The surveys in Qualtrics were made anonymous; no IP
address, location data, or contact info was collected. The participants identity remained
confidential. After the educational session, the post-survey was opened, and an email was sent
out 2 days after the educational session. The DNP candidate also used the informational letter
and added the post-survey QR code, and that flyer was left by the entrance of the conference
room for participants to scan and complete. The DNP candidate used the pre-and post-survey to
analyze and measure whether the participants knowledge improve after the educational session;
percentages from 0 to 100 was used to score the surveys.
Data Analysis
The surveys were kept password protected by the DNP candidate on Qualtrics. For the
pre-and post-survey, the DNP candidate scored the data with a percentage from 0 to 100. The
mean and median scores were calculated by the DNP candidate; scores ranged from 0 to 100.
The demographic section was scored by Qualtrics. Descriptive statistics was used to calculate all
statistical variables. The mean and median score percentages were used to compare the pre-and
post-survey. The DNP candidate used the Mann Whitney U test (Wilcoxon Rank Sum Test) to
obtain a p-value to evaluate whether there was no statistical significance between the pre-and
post-survey. An alpha value of 0.05 was used for the statistical test.
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Protection of Human Subjects
All investigators that were part of this QI project have completed the Collaborative
Institutional Training Initiative (CITI) training program in the protection of human research
subjects. Before implementing this QI project, the DNP candidate sought to obtain Institutional
Review Board (IRB) approval (Appendix B). A letter of support (Appendix A) was provided by
the administrator. Once IRB approval was obtained the immersion site administrator was made
aware to coordinate date and time of the educational session. The participants via email and in
person were informed that participation to this QI project is voluntary and by completing the presurvey questionnaire it means that they are consenting to participating in this QI project. A
recruitment letter (Appendix C) was attached via email and given in person which explained that
in total the QI project will take 60 minutes of the participants time. The participants were
informed that it will take 10-15 minute to complete pre-survey, 20-30 minute to complete
educational presentation, and 10-15 minute to complete post-survey. The data collected from the
pre-and post-survey was kept private and password protected. Only the members of the research
team had access to the data gathered on Qualtrics. There will be no identifiable data presented in
publications and in presentations. The DNP candidate was the only individual with password
access to Qualtrics. The data recorded on Qualtrics did not record the respondents IP address,
location data, and contact info.
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Chapter VII
Results
The purpose of this quality improvement project was to evaluate the impact of providing
an educational session on transgender stigma and discrimination and how it impacts the
transgender community willingness to participate in HIV screening. The DNP candidate aimed
to evaluate if a 20- to 30-minute educational session improved the knowledge of healthcare
professionals who work in a primary care clinic. Fifty-two potential participants were invited to
participate in the QI project. Twenty-three participants completed the pre-survey; 18 participants
attended the educational session, and those 18 participants completed the post-survey.
Demographics
Table 1
Pre-Survey Participant Demographic Data

Gender Identity
Cisgender-Male
Cisgender-Female
Transgender (Unspecified)
Transgender (M to F)
Transgender (F to M)
Non-Binary or Non-Confirming
Other; Please specify
Prefer not to say
Unanswered
Birth Sex
Male
Female
Intersex
Prefer not to say
Preferred Pronoun
He/him
She/her
They/them
Prefer not to say
Sexual Orientation
Gay

Count
(n=23)

Percent

3
15
0
1
0
0
0
2
2

13.04%
65.22%
0.00%
4.35%
0.00%
0.00%
0.00%
8.70%
8.70%

5
18
0
0

21.74%
78.26%
0.00%
0.00%

4
19
0
0

17.39%
82.61%
0.00%
0.00%

4

17.39%
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Lesbian
Heterosexual/Straight
Bisexual
Other; Please specify
Prefer not to say
Unanswered
Age
Under 18
18-24
25-34
35-44
45-54
55-64
65-74
75-84
85 or older
Highest Level of Education
High School/GED
Some College
Associate Degree in Progress
Associate Degree
Bachelor’s degree in Progress
Bachelor’s degree
Master’s degree in Progress
Master’s degree
Doctoral Degree in Progress
Doctorate/PhD Degree
Job Title
Medical Liaison
Phlebotomist
Patient Care Coordinator
Pharmacist
Pharmacist Technician
Physician
Physician Associate
Nurse Practitioner
Other; Please specify
Years in the Medical Field
Less than a year
1-2 years
3-5 years
6-10 years
11-20 years
20 years +
Do you provide care to transgender patients?
Yes
No
Have you received transgender or any
LGBTQ+ education?
Yes

0
14
4
0
0
1

0.00%
60.87%
17.39%
0.00%
0.00%
4.35%

0
2
11
3
7
0
0
0
0

0.00%
8.70%
47.83%
13.04%
30.43%
0.00%
0.00%
0.00%
0.00%

6
4
2
6
2
1
1
0
0
1

26.09%
17.39%
8.70%
26.09%
8.70%
4.35%
4.35%
0.00%
0.00%
4.35%

0
2
10
1
3
0
0
0
7

0.00%
8.70%
43.48%
4.35%
13.04%
0.00%
0.00%
0.00%
30.43%

2
4
6
5
4
2

8.70%
17.39%
26.09%
21.74%
17.39%
8.70%

19
4

82.61%
17.39%

17

73.91%
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No
If yes, how much education did you receive?
Less than 30 minutes
30 minutes to an hour
Hour or more; Please specify
Unanswered
If you did receive transgender and/or
LGBTQ+ education, please select in what
setting? Select all that apply.
High School Level
Undergraduate Level
Master/Graduate Level
Doctoral Level
On the Job

6

26.09%

1
6
10
2

5.26%
31.58%
52.63%
10.53%

2
2
0
0
17

11.76%
11.76%
0.00%
0.00%
100.00%

Pre-Survey Sample Demographics
The participants demographics are displayed in Table 1. Of the 23 participants in the presurvey sample, 15 (65.22%) identified as cis-gender female, three (13.04%) identified as
cisgender male, one (4.35%) identified as transgender (M to F), two (8.70%) preferred not to
disclose gender, and two (8.70%) did not chose an answer. Of these participants, 18 (78.26%)
identified their birth sex as female and five (21.74%) identified their birth sex as male. four
(17.39%) chose the prefer pronoun as he/him and 15 (65.22%) chose the prefer pronoun as
she/her. Four (17.39%) identified as gay or homosexual, 14 (60.87%) identified as heterosexual
or straight, four (17.39%) identified as bisexual, and one (4.35%) left the question unanswered.
Two (8.70%) were between the ages of 18-24, 11 (47.83%) were between ages 25-34, three
(13.04%) were between the ages of 35-44, and seven (30.43%) were between the ages of 45-54.
As for highest level of education, six (26.09%) have a high school/GED education, four
(17.39%) answered as having some college education, two (8.70%) have their associate degree in
progress, six (26.09%) have their associate degree, two (8.70%) have their bachelor’s degree in
progress, one (4.35%) has their bachelor’s degree, one (4.35%) has their master’s degree in
progress, and one (4.35%) has their doctorate/PhD degree. Two (8.70%) are phlebotomists, 10
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(43.48%) are patient care coordinators, one (4.35%) is a pharmacist, three (13.04%) were
pharmacist technicians, and seven (30.43%) chose other for job title and were asked to specify.
Those that chose other were medical office associates, practice administrator, outreach and
adherence specialist, and linkage. Participants were also asked how many years they have been
in the medical field, two (8.70%) had less than 2 years, four (17.39%) had 1-2 years in the
medical field, six (26.09%) have 3-5 years in the medical field, five (21.74%) had 6-10 years,
four (17.39%) had 11-20 years in the medical field, and two (8.70%) had 20 years or more.
Nineteen (82.61%) stated yes that they do provide care to transgender patients, and four
(17.39%) stated no that they do not provide care to transgender patients. From those 19 that
responded yes, one (5.26%) received less than 30 minutes of LGBTQ education, six (31.58%)
received 30 minutes to an hour of LGBTQ education, 10 (52.63%) received an hour or more, and
two (10.53%) left the question unanswered. Seventeen participants answered the final question,
which was a select all that apply on where they received LGBTQ+ education; two stated at the
high school level, two stated at the undergraduate level, and 17 answered on the job.
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Table 2
Post-Survey Participant Demographic Data

Gender Identity
Cisgender-Male
Cisgender-Female
Transgender (Unspecified)
Transgender (M to F)
Transgender (F to M)
Non-Binary or Non-Confirming
Other; Please specify
Prefer not to say
Birth Sex
Male
Female
Intersex
Prefer not to say
Prefer Pronoun
He/him
She/her
They/them
Prefer not to say
Sexual Orientation
Gay
Lesbian
Heterosexual/Straight
Bisexual
Other; Please specify
Prefer not to say
Unanswered
Age
Under 18
18-24
25-34
35-44
45-54
55-64
65-74
75-84
85 or older
Highest Level of Education
High School/GED
Some College
Associate Degree in Progress
Associate Degree
Bachelor’s degree in Progress
Bachelor’s degree

Count
(n=18)

Percent

5
12
0
1
0
0
0
0

27.78%
66.67%
0.00%
5.56%
0.00%
0.00%
0.00%
0.00%

6
12
0
0

33.33%
66.67%
0.00%
0.00%

5
12
1
0

27.78%
66.67%
5.56%
0.00%

1
0
12
4
0
0
1

5.56%
0.00%
66.67%
22.22%
0.00%
0.00%
5.56%

0
3
8
3
4
0
0
0
0

0.00%
16.67%
44.44%
16.67%
22.22%
0.00%
0.00%
0.00%
0.00%

1
2
3
3
1
2

5.56%
11.11%
16.67%
16.67%
5.56%
11.11%
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Master’s degree in Progress
Master’s degree
Doctoral Degree in Progress
Doctorate/PhD Degree
Unanswered
Job Title
Medical Liaison
Phlebotomist
Patient Care Coordinator
Pharmacist
Pharmacist Technician
Physician
Physician Associate
Nurse Practitioner
Other; Please specify
Unanswered
Years in the Medical Field
Less than a year
1-2 years
3-5 years
6-10 years
11-20 years
20 years +
Do you provide care to transgender patients?
Yes
No
Have you received transgender or any
LGBTQ+ education?
Yes
No
If yes, how much education did you receive?
Less than 30 minutes
30 minutes to an hour
Hour or more; Please specify
If you did receive transgender and/or
LGBTQ+ education, please select in what
setting? Select all that apply.
High School Level
Undergraduate Level
Master/Graduate Level
Doctoral Level
On the Job

1
1
2
1
1

5.56%
5.56%
11.11%
5.56%
5.56%

3
0
6
0
3
1
0
0
4
1

16.67%
0.00%
33.33%
0.00%
16.67%
5.56%
0.00%
0.00%
22.22%
5.56%

2
1
8
2
4
1

11.11%
5.56%
44.44%
11.11%
22.22%
5.56%

17
1

94.44%
5.56%

15
3

83.33%
16.67%

2
2
11

13.33%
13.33%
73.33%

1
1
0
2
11

6.67%
6.67%
0.00%
13.33%
73.33%

Post-Survey Demographics
For the post-survey, participants demographics are displayed in Table 2. Only 18 of the
23 participants completed the educational session and post-survey. Five (27.78%) identified as
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cis-gender male, 12 (66.67%) identified as cis-gender female, and one (5.56%) identified as
transgender (M to F). Six (33.33%) answered their birth sex as male, and 12 (66.67%) answered
their birth sex as female. Of those 18 participants, five (27.78%) preferred he/him pronoun, 12
(66.67%) preferred she/her, and one (5.56%) preferred they/them. One (5.56%) identified as gay
or homosexual, 12 (66.67%) identified as heterosexual or straight, four (22.22%) identified as
bisexual, and one (5.56%) left the question unanswered. Three (16.67%) were between the ages
of 18-24, eight (44.44%) were between the ages of 25-34, three (16.67%) were between the ages
of 35-44, and four (22.22%) were between the ages of 45-54.
As far as for high level of education, one (5.56%) completed high school or received a
GED, two (11.11%) received some college education, three (16.67%) had their associate degree
in progress, three (16.67%) had an associate degree, one (5.56%) had their bachelor’s degree in
progress, two (11.11%) had their bachelor’s degree, one (5.56%) had their master’s degree in
progress, one (5.56%) had their master’s degree, two (11.11%) had their doctoral degree in
progress, one (5.56%) had their doctoral degree, and one (5.56%) left the question unanswered.
Three (16.67%) were medical liaisons, six (33.33%) were patient care coordinators, three
(16.67%) were pharmacist technicians, one (5.56%) was a physician, four (22.22%) answered as
other and were either medical student, surgical coordinator, and outreach and adherence
coordinator, and one (5.56%) left question unanswered. Two (11.11%) had less than a year in the
medical field, one (5.56%) had 1-2 years in the medical field, eight (44.44%) had 3-5 years in the
medical field, two (11.11%) had 6-10 years in the medical field, 4 (22,22%) had 11-20 years in
the medical field, and one (5.56%) had 20 or more years in the medical field. Seventeen
(94.44%) answered yes to providing care to transgender patients, and one (5.56%) answered no.
Fourteen (77.78%) stated yes to having received LGBTQ + education, and four (22.22%) stated
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no. From those 15 that stated yes to receiving LGBTQ+ education, two (13.33%) received less
than 30 minutes of LGBTQ+ education, two (13.33%) received 30 minutes to an hour, and 11
(73.33%) received hour or more of LGBTQ+ education. Of those 15 participants who responded
yes, 1 (6.67%) received LGBTQ+ education at the high school level, 1 (6.67%) at the
undergraduate level, two (13.33%) at the doctoral level, and 11 (73.33%) received LGBTQ+
education on the job.
Pre-and Post-Survey Analysis
Table 3
Participants’ Knowledge on Transgender Stigma and Discrimination Pre- and Post-Survey
Scores
Question

Pre-Survey (n=23)

Post-Survey (n=18)

1. Which Statement
best defines gender
identity?
Personal sense of one’s own gender;
may not always match the sex
assigned at birth. Individuals
may identify themselves as man,
woman, or nonbinary.

20 (86.96%)

15 (83.33%)

2. What is the meaning of the term
“Nonbinary” or “Genderqueer”?
Used by those whose gender identity
or gender expression is not categorized
by male or female.

12 (54.55%)

16 (88.89%)

3. What is the definition for the term
Transgender?
An umbrella term for populations whose
gender identity does not fall into a traditional
cisgender category or differs from the one
assigned at birth.
4. True or False: Sexual Orientation and
gender identity is the same thing.

19 (82.61)

16 (88.89%)
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False

21 (91.30%)

18 (100.00%)

1 (4.55%)

10 (55.56%)

9 (40.91%)

16 (88.89%)

4 (18.18%)

8 (44.44%)

9 (39.13%)

10 (55.56%)

5. What percentage of transgender people
do you think reported negative experiences
in the healthcare setting?
33%
6. Which population faces the most bias
and discrimination?
Transgender women of color
7. According to the CDC, what is
the HIV prevalence
for transgender women?
14.1%
8. What ration of transgender
women have HIV?
4 in 10 transgender women
9. What percentage of black
transgender women do you think
have HIV?
62%

4 (17.39%)

8 (44.44%)

1 (4.35%)

11 (61.11%)

10. What percentage of HIV diagnosis
did the transgender community
received by mode of HIV
exposure in Broward County?
1%
11. What is the main interpersonal variable
that is making the transgender community
vulnerable to HIV?
Sexual Assault

4 (17.39%)

14 (77.78%)

12. Which structural and social determinant has
the highest percentage in putting pressure on
the transgender community?
Unemployment

1 (4.35%)

13 (72.22%)

13. Select all that apply: What information should be
added to the electronic health record system for
someone that does not identify with their birth sex?
Pronouns
Gender Identity

15 (65.22%)
19 (82.61%)

17 (94.44%)
16 (88.89%)
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Preferred name

12 (52.17%)

17 (94.44%)

14. True or False: Try to avoid using gender terms or
pronoun with new patient until this information is
known whether in person or over the phone.
True

20 (86.96%)

16 (94.12%)

15. Which statement should be used when asking a
transgender patient how they would like to be addressed?
I would like to be respectful. What name and pronouns
Would you like me to use?

16 (19.57%)

15 (88.24%)

Table 4
Mann Whitney U test (Wilcoxon Rank Sum Test) for The Statistically Significant Difference
Between Pre- and Post-survey
Pre-Survey
Sample Size
Sample Average
Sample Median
Sample SD

Post-Survey
23
43.77
46.67
13.90

P-Value
18
74.82
80.00
21.15

0.00001774
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Figure 2
The Mean Knowledge Scores on Transgender Stigma and Discrimination Pre- and PostSurvey

Pre- and Post-Mean Scores
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Figure 3
The Median Knowledge Scores on Transgender Stigma and Discrimination Pre- and PostSurvey

Pre-and Post-Survey Median Scores
100
90
80
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30
20

46.67
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Participants’ Knowledge on Transgender Stigma and Discrimination Pre- and PostIntervention Scores
The pre- and post-survey was scored on a scale of 0 to 100. The percentage of
participants who chose the correct answer for the 15 knowledge questions pre- and post-survey
are displayed in Table 3. Scores were shown to increase after the 20- to 30-minute educational
session. Figure 2 shows a bar graph of the mean scores of the pre- and post-surveys. Pre-survey
mean score was 43.77% and post-survey mean score was 74.82%. There was a 31.05% mean
increase from the pre-survey after the educational session was conducted. The Mann Whitney U
test (Wilcoxon Rank Sum Test) was used to analyze if there is no statistically significant
difference between the pre- and post-survey before and after the 30-minute educational
presentation. Table 4 contains the p-value. The result of the Mann Whitney U test was big
enough to be statistically significant based on an alpha value of 0.05. The null hypothesis can be
rejected since the p-value equals 0.00001774 <(a)0.05. This finding suggests that there is a
statistically significant difference between the pre-and post-survey. Median score for the presurvey was significantly lower than the median score for the post-survey. A bar graph of the
median scores is presented in Figure 3.
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Chapter VIII
Discussion
Demographics
The participants surveyed in this study work in the medical field and provide care to
transgender patients. Twenty-three participants completed the pre-survey, and 18 of the 23
participants attended the educational session and completed the post-survey. Based on the presurvey results, majority of the participants highest level of education was in either high
school/GED and associate degree. The majority have at least 3-5 years of medical field
experience. Nineteen of the 23 participants indicated that they care for transgender patients.
Seventeen out of the 23 received LGBTQ+ education before this educational session. The
majority indicated that they received an hour or more of LGBTQ+ training. Seventeen of the 19
participants stated that their LGBTQ+ education was received on the job. This is illustrated in
Table 1, where 17 out of the 17 participants who responded “yes” to receiving LGBTQ+
education that was on the job.
In the post-survey, the majority have their associate degree and/or their associate degree
is in progress. The majority of participants have 3-5 years of medical field experience. Seventeen
of the 18 participants stated that they do provide care to transgender patients. Only 15 out of the
18 received LGBTQ+ education. Of those 15, 11 responded with receiving an hour or more of
LGBTQ+ education, and 11 indicated that they received their LGBTQ+ education on the job.
Referring to the table of evidence, Eickhoff (2021), stated in their study that most health
profession schools offer fewer than 5 hours of LGBTQ+ education, and 18 nursing schools in the
study found that no content is taught related to LGBTQ+ education in undergraduate programs.
Arora et al. (2020) also found that majority of medical curricula in the United States lack or
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need further inclusion of transgender based healthcare education. These results indicated that
LGBTQ+ and/or transgender care education is not taught at school but mostly on the job.
Knowledge
The knowledge questions were scored on a scale of 0 to 100. The bar graph in Figure 2
illustrates the mean scores for the pre-and post-survey. Pre-survey mean score was 43.77 (SD
13.90) and the post-survey mean score 74.82 (SD 21.15). Table 4 indicates that the p-value was
less than the alpha value 0.05. This means that the null hypothesis was rejected and that there is a
statistical significance between the pre-and post-survey. Table 3 reveals the number and
percentage of participants who got the question correct on the pre- and post-survey. It can be
observed that after the 30-minute educational presentation, there is an increase in the number and
percentage of participants selecting the correct answer. For survey question five, one person got
the question correct on the pre-survey, but after the educational presentation, 10 participants got
the question correct. The same can be observed for question 11, where four participants
answered the question correct and after the educational presentation, 14 participants chose the
correct answer on the post-survey. Figure 3 illustrates the median scores for the pre-and postsurvey. The median score for the pre-survey was 46.67% and the median score for the postsurvey was 80.00%. These findings suggest that after conducting a 30-minute educational
session on transgender stigma and discrimination in healthcare setting improved participants
knowledge based on the post-survey mean and median scores. Referring to the table of
evidence, Arora et al. (2020) in their study exhibited similar results where providers were given
education on transgender people and their study demonstrated a substantial change in clinician
attitudes after education. 80% of their participants identified education as a key strategy to
improve delivery of transgender care (Arora et al., 2020). These findings indicate that after the
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30-minute educational session, the participants’ knowledge on transgender stigma and
discrimination and how it impacts their willingness to participate in HIV screening did increase.
Thus, an educational session can improve healthcare providers’ knowledge on transgender access
to care, which can improve the quality of care provided in the healthcare setting.
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Chapter IX
Limitations
Several limitations were found for the QI project findings. For the pre-survey, only 23
participants completed the pre-survey questionnaire which is less than half of the total staff of
the clinic, thus limiting the generalizability of these findings. Second, 18 of the 23 participants
who completed the pre-survey attended the educational session and completed the post-survey
which is a much smaller group. Not all participants answered every question; some questions
were left unanswered on both the demographic and knowledge sections.
The DNP candidate developed the survey questions from evidence-based literature
articles. Furthermore, the educational session was time limited. There is a possibility that if more
time had been given to provide content on transgender care, then more participants may have
been able to attend. Although the rate of participants was small, a strength of the project is that it
was attended by individuals who care for transgender patients. Regardless of these limitations,
these study findings suggest that there is a need of transgender care education in school and that
their knowledge on transgender care can improve by providing educational sessions on this topic.
By providing education on transgender care, healthcare providers will be more culturally
competent, which will improve the quality of care provided to transgender patients.
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Chapter X
Implications for Advanced Practice Nursing
Nurses are in the forefront of medicine. At most times, nurses are the first healthcare
professionals that a patient interacts with. Nurses should understand what the term transgender
means and how to care for patients that identify as transgender. Understanding or having basic
knowledge on transgender care is not enough. Nurses need to be culturally educated on the
stigma and discrimination that the transgender community faces in the healthcare setting. Nurses
should be trained on how to properly interact and/or communicate with a patient whose gender
does not match their birth sex. Nurses need to understand that there is a stigma associated with
HIV and how that can furtherly affect a transgender person’s willingness to participate in HIV
screening.
The next steps for this QI project are for there to be more educational sessions on
transgender and/or LGBTQ+ care in healthcare settings. Based on the data gathered, healthcare
settings especially those that are LGBTQ+ friendly are doing their part in educating their staff in
transgender care. More healthcare organizations should follow this example whether they have a
lot of LGBTQ+ patients or not. There is a lack of LGBTQ+ education the academic setting as
well. Advanced Practice Registered Nurses (APRNs) should target the academic setting and
evaluate how much LGBTQ+ education is being provided in the undergraduate/graduate setting.
The plan for sustaining practice change is to continue offering educational sessions every
6 months or 12 months. These educational sessions can be beneficial especially for new staff that
is hired mid-year. Transgender/LGBTQ+ care educational sessions can also be added as
competencies for employees to complete in their mid-annual/annual evaluations. Making these
educational sessions mandatory can help in sustaining the practice change in the healthcare
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clinic. These educational sessions can help in bringing awareness on the stigma and
discrimination that transgender individuals experience in the healthcare setting and how this
impacts them from seeking healthcare services. These educational sessions can also include how
to properly communicate with an individual whose gender identity/expression differs from their
birth sex. Patient interaction begins at the front desk by providing transgender/LGBTQ+
education to the healthcare personnel can help bring in a positive experience to transgender
patients when visiting the medical setting.
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Chapter XI
Conclusion
Transgender patients experience stigma and discrimination in the healthcare setting that
has affected their participation in HIV screening. Transgender patients tend to avoid the
healthcare setting due to fear of getting discriminated, refusal of care, sexually/physical assault,
being blamed for their health conditions, or having to educate the healthcare provider on how to
properly care for them. Some healthcare providers may not be properly trained on how to interact
with transgender patients, which can furtherly impact their interaction with these patients.
Furthermore, there is a lack of LGBTQ+ education in the academic setting. This can be referred
to the table of evidence and literature review where several articles mentioned the lack of
LGBTQ+ education in the school settings. Based on the data gathered, most or all participants
who care for transgender patients were provided with LGBTQ+ education on the job.
Lastly, these findings suggest that healthcare professionals may benefit from an
educational intervention focused on transgender stigma and discrimination and how it impacts
their participation in HIV screening. Further studies should be geared on the academic setting to
evaluate how much education does each healthcare discipline receives on LGBTQ+ care and
how to incorporate that education to the curricula. Thus, by educating healthcare professionals
and improving their knowledge on how stigma and discrimination in the healthcare setting
affects the transgender community should bring awareness to enhance the quality of care
provided in the primary care setting.
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after 7 days.

Andrzejewski, J.,
Dunville, R., Johns,
M. M., Michaels, S.,
& Reisner, S. L.
(2021). Medical
gender affirmation and
HIV and sexually
transmitted disease
prevention in
transgender youth:
Results from the
survey of today’s
adolescent
relationships and
transitions, 2018.
LGBT Health, 8(3),
181–189. https://doiorg.ezproxylocal.librar
y.nova.edu/10.1089/lg
bt.2020.0367

Purpose was to
assess the
association of
receipt of
medical
gender
affirmation
services with
HIV and other
sexually
transmitted
diseases (STD)
prevention and
knowledge
indicators
among
transgender
youth.

Cross
sectional
survey
including
questions
about
sociodemographics,
medical
gender
affirmation,
and HIV and
STD
prevention
outcomes
(HIV
testing, STD
testing,
PrEP and
nonoccupati
onal PEP
awareness).

Participants’
Characteristics;
Sampling/Setting
Participants were
at least 15 years
old and were
newly diagnosed
and started on
ART between
October 2016 and
July 2018 in 11
health facilities in
the Amhara
region of
Ethiopia.

Intervention

Results

Multivariable
logistic
regression
controlling
for potential
confounders
and KaplanMeier
survival
analysis were
used to assess
differences in
outcomes
between the
groups.

United States
online sample of
sexually
experienced
transgender youth
ages 13-24 years
in 2018.

Logistic
regression
models were
fit to assess
the
association of
medical
gender
affirmation
with HIV and
STD
prevention
outcomes;
interaction
terms and
stratified
model’s
differences in
the
association
between
gender
affirmation
and outcomes
by gender
identity.

The major drop
in retention was
in the first 30
days following
ART initiation
among same
day
group. After
adjusting for
baseline and
non-baseline
covariates, the
same-day group
was less likely
to be retained-in
care
at 6 and
12months
Medical gender
affirmation was
associated with
increased odds
of STD testing
with no
significant
interactions by
gender identity.
Associations
between
medical gender
affirmation and
awareness of
PrEP and nPEP
varied by
gender identity.
Among
transgenders
male youth,
medical gender
affirmation was
associated with
awareness of
PrEP and nPEP.
Among
nonbinary
youth, medical
gender
affirmation was
associated with
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Arora, M., Walker, K.,
Luu, J., Duvivier, R.
J., Dune, T., &
Wynne, K. (2020).
Education of the
medical profession to
facilitate delivery of
transgender healthcare
in an australian health
district. Australian
Journal of Primary
Health, 26(1), 17–23.
https://doiorg.ezproxy.fiu.edu/10
.1071/PY19102

The study
explores the
attitudes of the
local
transgender
community to
their health
services and
the confidence
of local
healthcare
providers to
deliver care.

Brennan, J., Kuhns, L.
M., Johnson, A. K.,
Belzer, M., Wilson, E.
C., & Garofalo, R.
(2012). Syndemic
theory and HIVrelated risk among
young transgender
women: The role of
multiple, co-occurring
health problems and
social
marginalization. Ameri
can Journal of Public
Health, 102(9), 1751–
1757.
https://doi.org/10.2105
/AJPH.2011.300433

The purpose of
the study is to
assess whether
multiple
psychosocial
factors are
additive in
their
relationship to
sexual risk
behavior and
self-reported
HIV status
among young
transgender
women could
be
characterized
as a syndemic
and assess the
relationship of
indicators of
social
marginalizatio
n, such as a
history of
commercial
sex work,
homelessness,
and
incarceration,
to these

An
anonymous
survey was
distributed
to the
transgender
community.
Healthcare
providers
also
participated
in an
anonymous
survey. An
educational
session was
used to
deliver
transgender
care
education.
A
community
based
participatory
research
model to
conduct a 2phase cross
sectional
study
examining
HIV-related
risk
behavior
among
young
transgender
women in
Chicago and
Los
Angeles.

Participants were
identified by
healthcare
professionals
through local
support groups
and social media.
The educational
session and
surveys for
providers were
done at
universities, at a
GP annual
conference, and
hospital.

A pre-and
post-survey
was used as
well as a 1hour
educational
session to
healthcare
providers was
conducted.

Transgender
women were
recruited from
medical clinic
settings; in social
venues, such as
bars and clubs and
through street
outreach and
referrals from
study participants.
Eligibility criteria
were selfidentifying as a
transgender
woman or not
identifying with
assigned male
birth gender,
residing in the
Chicago or Los
Angeles metropolitan area, being
able to speak and
understand either
English or
Spanish, and
being aged 15 to
24 years. We
obtained
a waiver of
parental consent
for participants

Data were
collected
through an
interviewer
administered
survey, with
questions
regarding
general
demographic
characteristic
s, HIV risk
behaviors,
indicators of
social
marginalizati
on, as well
psychosocial
health status.
When
possible, used
items from
existing
questionnaire
s or modified
them to be
sensitive and
appropriate
for young
transgender
women. The
transgender
advisory

awareness of
PrEP.
The community
survey
demonstrated
the need for
improved
knowledge and
understanding
from healthcare
providers.

Results revealed
that multiple
health-related
psychosocial
factors low selfesteem, lifetime
polysubstance
use, intimate
partner
violence, and
victimization
may be additive
in their
association with
sexual risk
behavior and
self-reported
HIV infection
among young
transgender
women.
Although there
was no
significant
association
between 1
syndemic factor
and sexual risk
and 1 to 2
syndemic
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psychosocial
factors.

Eickhoff, C. (2021).
Identifying gaps in
LGBTQ health
education in
baccalaureate
undergraduate nursing
programs. Journal of
Nursing Education,
60(10), 552–558.
https://doi.org/10.3928
/01484834-2021072901

The purpose
was to provide
an overview of
the quantity
and quality of
LGBTQ health
education,
perceived
barriers to
appropriate
LGBTQ
education, and
the need for
support and

Cross
sectional
descriptive
design. A
survey was
used.

aged 15 to 17
years and written
consent (or assent
from minors)
prior to study
participation.
Participants
received a $25
incentive for
completion of the
study.

committee
reviewed and
approved the
entire survey
instrument.

Undergraduate
nursing students
who schools are
accredited by the
commission on
Collegiate
Nursing
Education.
School deans,
chairs, and
directors were
asked to complete
the survey about
the

The survey
was
distributed
anonymously
via Qualtrics
software on
September
26, 2019;
three
periodic
reminder
emails were
sent before

factors and
seropositivity,
this may be a
function of
small sample
size. The
additive trend in
these factors in
their
relationship to
sexual risk
behavior and
HIV status
among young
transgender
women are
similar to
previous
findings among
urban MSM and
ethnically
diverse young
MSM. The
findings
highlight the
social situations
or life
experiences that
are associated
with these
conditions. A
history of sex
work and
incarceration,
which
contribute to
these cooccurring
conditions and
their resulting
heightened HIV
risk.
Nearly twothirds of
responding
schools
indicated
their graduates
were not
adequately
prepared to care
for
this population,
and 38% of
schools agreed
their faculty had

70
education for
faculty
concerning the
implementatio
n.

Fisher, C. B., Fried, A.
L., Desmond, M.,
Macapagal, K., &
Mustanski, B. (2018).
Perceived barriers to
HIV prevention
services for
transgender youth.
LGBT health, 5(6),
350–358.
https://doi.org/10.1089
/lgbt.2017.0098

The purpose of
this was to
explore the
transgender
youth’s
perceptions
regarding
encounters
with primary
care providers
(PCPs) related
to gender and
sexual
minority
(GSM)
identity and
sexual health.

The data
reported
here are part
of a larger
Internetbased survey
on
transgender
youths'
experiences
with and
attitudes
toward
sexual
health
research and
services,
conducted in
spring
2016.

whole school or to
delegate
completion of the
survey to another
faculty member
able to gather the
requested
information.

the survey
closed on
January 15,
2020.

the knowledge
needed to
adequately
teach this
content.
Barriers
included time
constraints and
lack of faculty
knowledge.

Participants were
recruited
primarily through
Facebook paid
posts that directed
viewers to a page
providing a brief
study description
and link to a
seven-item
screening
questionnaire. The
screener questions
assessed
eligibility using
the following
inclusion criteria:
age 14–21 years,
identifying as
transgender, and
living in the
United States.

A survey on
GSM identity
disclosure
and
acceptance,
genderaffirming
services,
sexual health
attitudes and
behaviors,
and
interactions
with PCPs
involving
GSM identity
and concerns
about stigma
and
confidentialit
y.

Items from the
GSM Stigma
scale revealed
that nearly half of
respondents had
not disclosed
their GSM
identity to their
PCP due to
concern about an
unaccepting PCP.
One-quarter of
youth were less
inclined to
discuss GSM
identity and
sexual health with
their PCP due to
concern that their
provider would
disclose this
information to
parents; these
concerns were
greater among
adolescents <18
and those not out
to parents about
their gender
identity. Only
25% felt their
PCP was helpful
about GSMspecific sexual
health issues.
Youth who were
out to parents
about their gender
identity and had
received genderaffirming
hormone therapy
was more likely
to report
receiving GSMspecific sexual
health
information.
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Jadwin-Cakmak, L.,
Reisner, S. L., Hughto,
J., Salomon, L.,
Martinez, M., Popoff,
E., Rivera, B. A., &
Harper, G. W. (2019).
HIV prevention and
HIV care among
transgender and
gender diverse youth:
Design and
implementation of a
multisite mixedmethods study
protocol in the U.S.
BMC public health,
19(1), 1531.
https://doi.org/10.1186
/s12889-019-7605-4

The purpose of
this paper is to
describe the
development
of the study
protocol,
research
methods, and
lessons learned
from
the U.S.-based
“Affirming
Voices for
Action” study,
a multi-site,
mixed
methods study
that explored
TGD
youth's
experiences of
engagement in
the HIV
prevention
and care
continua.

Engagement
of TGD
youth across
the HIV
prevention
and care
continua
was assessed
using a
multiphasic
mixedmethods
study
design. Both
quantitative
survey
data and indepth
qualitative
interview
data were
collected
from TGD
youth as
well as from
healthcare
providers
who had
experience
working
with TGD
youth.

A sample of TGD
youth and
healthcare and
social service
providers serving
TGD youth were
recruited for the
study
from across the 14
U.S. sites: Tampa,
FL; Los Angeles,
CA;
Washington, DC;
Philadelphia, PA;
Chicago, IL; New
York, NY; New
Orleans, LA;
Miami, FL;
Memphis, TN;
Houston, TX;
Detroit, MI;
Baltimore, MD;
Boston, MA;
and Denver, CO.

The
quantitative
survey for
TGD youth
elicited
information
regarding the
facilitators
and barriers
to
engagement
with each
stage of the
HIV care
continua
(prevention,
diagnosis,
linkage to
care,
engagement
in
care,
retention in
care,
initiation of
ART, and
viral
suppression).
The semistructured
qualitative
interview
guide for
TGD youth
was
developed in
collaboration
with the
Youth
Advisory
Board and
Protocol
Team using
an
iterative
process of
community
feedback and
revisions,
as well as a
secondary
analysis of
qualitative
data from
ATN 039.

Findings have
implications for
the
development of
HIV
interventions
across levels to
support the
health and wellbeing of TGD
youth. Future
research is
warranted to
replicate and
expand on
lessons
learned
regarding
recruitment and
engagement of
communities of
TGD youth,
including
longitudinal
designs to
assess
engagement
across their
developmental
stages.
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Leite, B. O., de
Medeiros, D. S.,
Magno, L., Bastos, F.
I., Coutinho, C., de
Brito, A. M.,
Cavalcante, M. S., &
Dourado, I. (2021).
Association between
gender-based
discrimination and
medical visits and
HIV testing in a large
sample of transgender
women in northeast
Brazil. International
Journal for Equity in
Health, 20(199).
https://doi.org/10.1186
/s12939-021-01541-z

The purpose of
the study is to
investigate the
putative
association
between
gender-based
discrimination
(GBD) and
medical visits
in the last 12
months and
HIV testing in
the last 12,
months,
among
transgender
women
(TGW) from
large capital
cities in
Northeast
Brazil.

The study
reports
findings
from a cross
sectional
biological
and
behavioral
surveillance
survey
among
TGW,
conducted in
three large
capitals of
northeastern
Brazil.

TGW (864) were
selected from the
cities of Salvador
(166), Recife
(350) and
Fortaleza (348) in
2017. They were
recruited using
respondent-driven
sampling (RDS)
as
a sampling
method aiming to
obtain a more
robust and
diverse sample.
They were
eligible for the
study if they
self-identified
themselves as
transgender
women, women,
or other category
different from the
male sex
designated
on their birth
certificate,
reported spending
most of their
time at the
selected city.

As needed by
the RDS
method; 5
and 10 initial
participants
in each city
called seeds
were chosen
purposively,
following
formative
qualitative
research only
as an initial
stage for
recruitment.
The
formative
phase of the
study
comprised
group
discussions
with local
TGW leaders,
nongovernmental
organizations
(NGO),
potential
participants,
and
researchers.
Each seed
received three
coupons to
distribute to
other TGW
from her
social
networks.
The
interviewees
recruited by
the seeds
were
defined as the
first wave of
the study.
After
participating
in the
interview,
each
participant

Results revealed
that GBD was
associated with
a reduced
likelihood of
medical visits in
the last 12
months. The
estimated
frequency of
medical visits in
the last year
among TGW
was relatively
low (67.0%)
compared
to other studies
conducted in
the United
States (US) of
America.
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Logie, C. H.,
Lacombe-Duncan, A.,
Brien, N., Jones, N.,
Lee-Foon, N.,
Levermore, K.,
Marshall, A., Nyblade,
L., & Newman, P. A.
(2017). Barriers and
facilitators to HIV
testing among young
men who have sex
with men and
transgender women in
Kingston, Jamaica: A
qualitative study.
Journal of the
International AIDS
Society, 20(1), 21385.
https://doi.org/10.7448
/IAS.20.1.21385

The purpose of
the study was
to explore
perceived
barriers and
facilitators to
HIV testing
uptake among
young
transgender
women and
MSM in
Jamaica.

A
communitybased
research
project in
collaboratio
n with HIV
and lesbian,
gay,
bisexual and
transgender
(LGBT)
agencies in
Kingston.

Research involved
53 semi-structured
individual
interviews: 20
with young gay,
bisexual and other
MSM, 20 with
young transgender
women, and 13
with key
informants from
LGBT agencies,
HIV clinicians
and outreach
workers in
Kingston,
Jamaica.

Mueller, S. C., De
Cuypere, G., &
T'Sjoen, G. (2017).
Transgender research
in the 21st century: A
selective critical
review from a
neurocognitive
perspective. The
American Journal of
Psychiatry, 174(12),
1155–1162.
https://doi.org/10.1176
/appi.ajp.2017.170606
26

The purpose of
this literature
is to examine
common
mental health
issues, several
individual risk
factors for
psychiatric
comorbidity,
and current
research on the
underlying
neurobiology
in transgender
people.

A selective
critical
review was
conducted.

Keywords that
were used to find
articles during the
search were
affective
disorders, gender
dysphoria,
suicidality,
transgender.

received three
additional
coupons to
distribute to
their peers.
This process
was repeated
until a define
sample size
was achieved
in each site.
Participants
completed a
brief sociodemographic
questionnaire
prior to
beginning the
interview or
focus group.

A metaanalysis was
used.

Barriers to HIV
testing included
mistreatment by
medical staff,
confidentiality
concerns, and
HIV-related
stigma: these
spanned
interpersonal,
community and
structural
levels.
Facilitators for
testing included
structural
(access to HIV
testing), social
(social support),
and individuallevel factors
(benefits of
knowledge).
Prevalence of
number of
people
presenting to
gender clinics is
increasing,
evidence of
biological
etiology is still
limited, trans
persons
experience a
high rate of
affective
disorders,
especially
depression and
anxiety, as well
as a high
risk of
suicidality and
non-suicidal
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Neumann, M. S.,
Finlayson, T. J., Pitts,
N. L., & Keatley, J.
(2017).
Comprehensive HIV
prevention for
transgender persons.
American Journal of
Public Health, 107(2),
207–212.
https://doi.org/10.2105
/AJPH.2016.303509

The purpose of
this article is
to summarize
the nature of
transgender
persons’ risks
for HIV
infection,
present the
best-evidence
prevention that
is available
and how to
apply that
prevention in
transgender-

Several
databases
were used to
find articles
that helped
with the
purpose of
the article.

Key terms were
used such as HIV
prevention,
transgender
people, HIV
infection
epidemiology, and
HIV infection risk
factors.

A metaanalysis was
used.

self-injury,
recent research
trends include
preliminary
findings of
elevated autistic
traits in trans
persons, gender
affirming
surgery and/or
cross-sex
hormone
treatment
decrease mental
health
problems, body
uneasiness,
and gender
dysphoria but
not necessarily
suicidality, a
high rate of
trans persons
find
discrimination
both in
personal and
professional
lives, search for
neurobiological
correlates of
transgenderism
is still ongoing
and there have
been promising
functional MRI
findings in
voice
perception and
olfaction.
A transgender
person’s risk of
HIV infection is
exacerbated
by complex
social
determinants
and intersecting
social and
gender identities,
comprehensive
HIV prevention
for this
population is
warranted.
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specific and
sensitive ways,
and elaborate
on
immediately
available
options for a
comprehensive
HIV
prevention
approach for
transgender
people.
Poteat, T., Malik, M.,
Scheim, A., & Elliott,
A. (2017). HIV
prevention among
transgender
populations:
Knowledge gaps and
evidence for action.
Current HIV/AIDS
Reports, 14(4), 141–
152.
https://doi.org/10.1007
/s11904-017-0360-1

The purpose of
this study is to
summarize the
available
evidencebased HIV
prevention
intervention
tailored for
transgender
people.

Several
databases
were used to
find research
articles
pertaining to
the focus of
the analysis.

Keywords such as
transgender, HIV
prevention,
stigma, structural
determinants,
behavioral
interventions, and
biomedical
interventions were
used.

A metaanalysis was
used.

Multilevel
sustained
interventions
are needed to
have a
population
level impact.
Interventions
that
concurrently
address
health,
psychosocial,
and economic
needs, as well
as legal and
policy reforms,
may have the
greatest
potential to
curtail new
infections in
transgender
communities. In
addition,
following
from the
Gender
Affirmation
Framework,
interventions
that
address
communityidentified needs
related to social
and
medical gender
affirmation may
be particularly
effective, as
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Reback, C. J., Clark,
K. A., Rünger, D., &
Fehrenbacher, A. E.
(2019). A promising
PrEP navigation
intervention for
transgender women
and men who have sex
with men experiencing
multiple syndemic
health disparities.
Journal of Community
Health, 44(6), 1193–
1203.
https://doi.org/10.1007
/s10900-019-00705-x

The purpose of
this study was
to test the
effect of a
PrEP peer
navigation
program,
A.S.K.-PrEP
(Assistance
Services
KnowledgePrEP_ among
trans women
and men who
has sex with
men (MSM) in
the Los
Angeles
County.

The study
examined
PrEP
linkage,
uptake, and
preliminary
adherence at
90 day
follow up
evaluation
among a
sample of
highly
impacted
trans women
and MSM
and tested
the outcome
differences
between the
two groups.

Over an 18-month
enrollment period,
from September
2016 to March
2018, 187
participants
enrolled in the
program (MSM =
129; trans women
= 58).

A.S.K.-PrEP
is a fivesession peer
navigator
service
program;
design to link
HIV negative
patients to
PrEP care.
The
intervention
was
conducted
over three
months.
Session one
began with
the
administratio
n of a PrEP
knowledge
pre-test. In
sessions two
through five,
participants
were assessed
for readiness
for PrEP
adherence
and planning
for
adherence,
removal of
structural and
individual
barriers,
access
to
documentatio
n
(identification
cards that are
required for
PrEP
initiation),
and continued
linkage,

these unmet
needs can
interfere or
compete with
HIV prevention
and treatment
uptake and
adherence.
Most
transgender
females and
MSM reported
they were still
taking PrEP at
the 90-day
follow up
evaluation. This
indicated that
A.S.K. PrEP is
a promising
intervention for
PrEP linkage,
uptake and
preliminary
adherence
among
transgender
women and
MSM.
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Sundus, A., Shahzad,
S., & Younas, A.
(2021). Ethical and
culturally competent
care of transgender
patients: A scoping
review. Nursing
Ethics, 28(6), 1041–
1060.
https://doi.org/10.1177
/0969733020988307

The study aims
to synthesize
the literature
and identity
gaps about
approaches to
the provision
of ethical and
culturally
competent care
to transgender
populations.

A scoping
review was
conducted
based on
these steps:
development
of the
question,
identificatio
n of relevant
articles,
selection of
articles,
extraction,
and charting
of data; and
synthesis
and
reporting of
findings.

Literature was
searched within
CINAHL, Science
Direct, PubMed,
Google Scholar,
EMBASE, and
Scopus databases
using indexed
keywords such as
“transgender,”
“gender nonconforming,”
“ethically
sensitive care,”
and “culturally
sensitive care. In
total, 30 articles,
which included
transgender
patients and their
families and
nurses, doctors,
and health
professionals who
provided care to
transgender
patients, were
selected for
review.

uptake, and
adherence
support.
Data were
extracted and
synthesized
using tabular
and narrative
summaries
and thematic
synthesis.

The review
identified that
healthcare
professionals
should educate
themselves
about sensitive
issues, become
more selfaware, put
transgender
individual in
charge during
care
interactions,
and adhere to
the principles of
advocacy,
confidentiality,
autonomy,
respect, and
disclosure.
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Appendix B
Office of Research Integrity
Research Compliance, MARC 414

MEMORANDUM
To:

Dr. Eric Fenkl

CC:

Steven Cardenas

From:

Elizabeth Juhasz, Ph.D., IRB Coordinator

Date:

June 16, 2022

Protocol Title:

"Improving Transgender Patients’ Access to Care in the Primary Care
Setting: A Quality Improvement Project"

The Florida International University Office of Research Integrity has reviewed your research
study for the use of human subjects and deemed it Exempt via the Exempt Review process.
IRB Protocol Exemption #:
TOPAZ Reference #:

IRB-22-0281
111951

IRB Exemption Date:

06/16/22

As a requirement of IRB Exemption you are required to:
1) Submit an IRB Exempt Amendment Form for all proposed additions or changes in the
procedures involving human subjects. All additions and changes must be reviewed and
approved prior to implementation.
2) Promptly submit an IRB Exempt Event Report Form for every serious or unusual or
unanticipated adverse event, problems with the rights or welfare of the human subjects, and/or
deviations from the approved protocol.
3) Submit an IRB Exempt Project Completion Report Form when the study is finished or
discontinued.
Special Conditions:

N/A

For further information, you may visit the IRB website at http://research.fiu.edu/irb.
EJ
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Appendix C

Recruitment Letter
Recruitment email for DNP Project: “Improving Transgender Access to Care in the Primary Care
Setting: A Quality Improvement Project”

Dear Participants
My name is Steven Cardenas, and I am a student from the Graduate Nursing Department at
Florida International University (FIU). I am writing to invite you to participate in my quality
improvement project. The goal of this project is to improve health care staffs’ knowledge of
transgender stigma and discrimination in the health care setting and how it affects their
willingness to participate in HIV screening. You are eligible to take part in this project because
you provide or may provide care and/or help to transgender patients.
If you decide to participate in this project, you will be asked to complete a pre-test questionnaire,
which is expected to take approximately 10-15 minutes. By completing the pre-test questionnaire
then you are consenting to participating in this quality improvement project. After, you will be
presented with an approximately 20-30-minute-long educational presentation (dates to the
presentation will be announced on a future date). After completing the educational presentation,
you will be asked to complete the post-test questionnaire, which is expected to take
approximately 10-15 minutes. No compensation will be provided.
Remember, this is completely voluntary. You can choose to be a part of the study or not and
withdraw at any time. If you’d like to participate, please click on the link provided below. Please
keep in mind that if you complete the pre-test questionnaire link, you are consenting to
participating in this quality improvement project (link for Qualtrics questionnaire). If you have
any questions about the study, please contact me via email at scard041@fiu.edu or call at 954778-5347. Thank you for your time and consideration.
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Appendix D

INFORMATIONAL LETTER
Improving Transgender Access to Care in the Primary Care Setting: A Quality Improvement
Project
Hello, my name is Steven Cardenas. You have been chosen at random to be in a research study
about transgender stigma and discrimination in the health care setting. The purpose of this study
is to assess health care professionals’ knowledge about transgender stigma and discrimination in
the health care setting and how it impacts the transgender community’s willingness to participate
in HIV screening. If you decide to be in this study, you will be one of 48 people in this research
study. Participation in this study will take 60 minutes of your time. If you agree to be in the
study, I will ask you to do the following things:
1. Complete a 10–15-minute pre-test questionnaire (completing pre-test questionnaire means
you are consenting to participating in this quality improvement project).
2. Attend a 20–30-minute educational presentation (dates to the presentation will be announced
on a future date).
3. Complete a 10–15-minute post-test questionnaire.
There are no foreseeable risks for participating in this study. There are benefits to participating in
this study such as understanding the challenges that a transgender individual may face when
wanting to access health care services. It is expected that this study will benefit society by
creating a positive environment for transgender individuals in the health care setting.
There is no cost or payment to you. If you have questions while taking part, please stop me and
ask. You will remain anonymous; all your answers are confidential. The pre-and post-test
questionnaire will not be asking any of your personal information.
If you have questions for one of the researchers conducting this study, you may contact Steven
Cardenas at 954-778-5347.
If you would like to talk with someone about your rights of being a subject in this research study
or about ethical issues with this research study, you may contact the FIU Office of Research
Integrity by phone at 305-348-2494 or by email at ori@fiu.edu. Your participation in this
research is voluntary, and you will not be penalized or lose benefits if you refuse to participate or
decide to stop. You may keep a copy of this form for your records
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Appendix E

Pre-Test and Post-Test
Improving Transgender Access to Care in the Primary Care Setting: A Quality Improvement
Project
Introduction:
This questionnaire is an important part of the quality improvement project aiming to address the
stigma and discrimination that the transgender community experiences in the health care setting and how
it impacts their willingness to participate in HIV screening.
Please all the questions with the best of your knowledge. Your response will assist in
understanding your knowledge on this topic. The questions will help in evaluating if you have had
transgender education as well as your knowledge about the stigma and discrimination that the transgender
community faces and how it impacts their willingness for HIV screening.

•

Please do not write your name or other personal information of this
questionnaire

•

Your answers are anonymous and will be kept confidential

•

Your participation is voluntary and will not have any bearing on your position

84
Demographics
1. What is your gender identity?
a. Cisgender-Male
b. Cisgender-Female
c. Transgender (Unspecified)
d. Transgender (M to F)
e. Transgender (F to M)
f. Non-Binary or Non-Conforming
g. Other; please specify
h. Prefer not to say
2. What is your birth sex?
a. Male
b. Female
c. Intersex
d. Prefer not to say
3. What is your prefer pronoun? Select all that apply.
a. He/him
b. She/her
c. They/them
d. Other
e. Prefer not to say
4. What is your sexual orientation?
a. Gay
b. Lesbian
c. Heterosexual
d. Bisexual
e. Other; Please specify ________
f. Prefer not to say
5. What is your age range?
a. Under 18
b. 18-24
c. 25-34
d. 35-44
e. 45-54
f. 55-64
g. 65-74
h. 75-84
i. 85 or older
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6. What is your highest level of education?
a. High School Diploma/GED
b. Some college
c. Associates degree in progress
d. Associates
e. Bachelor’s degree in progress
f. Bachelor’s degree
g. Master’s degree in progress
h. Master’s degree
i. Doctoral degree in progress
j. Doctorate/PhD degree
7. What is your job title?
a. Medical liaison
b. Phlebotomist
c. Patient care coordinator
d. Physician
e. Physician associate
f. Nurse practitioner
g. Other; please specify_______
8. How long have you worked in the medical field?
a. Less than a year
b. 1-2 years
c. 3-5 years
d. 6-10 years
e. 11-20 years
f. 20 years +
9. Do you provide care to transgender patients?
a. Yes
b. No
10. Have you received transgender care education?
a. Yes
b. No
11. If yes, how much transgender education have you received?
a. Less than 30 minutes
b. 30 minutes to an hour
c. Hour or more please specify_______________________
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12. If you did receive transgender care education, please select in what setting? Select
all that apply.
a. High school level
b. Undergraduate level
c. Masters/Graduate level
d. Doctoral level
e. On the job
Knowledge Questions
1. What is gender identity?
a. Person’s name, pronouns, clothing, haircut, behavior, voice, and body
characteristics. Can be described as either masculine or feminine.
b. Used by those whose gender identity or gender expression is not categorized by
male or female.
c. Personal sense of one’s own gender; May not always match the sex assigned at
birth. Individuals may identify themselves as man, women, or nonbinary.
d. Person’s physical emotional, or romantic attraction to another.
2. What is the meaning of the term “Nonbinary” or “Genderqueer”?
a. Used by those whose gender identity or gender expression is not categorized by
male or female.
b. Defined as an individual who identifies with their assigned sex at birth.
c. Defines an individual who does not identify with their assigned sex and associated
gender that they were assigned at birth.
d. Defined as a person who identifies as two genders.
3. What is the definition for the term transgender?
a. The romantic, emotional, and/or sexual attraction to people regardless of their
gender.
b. An umbrella term for populations whose gender identity does not fall into a
traditional cisgender category or differs from the one assigned at birth.
c. A person who identifies outside of male or female or may go back and forth
between different gender identities.
d. The process of transformation from an immature form to an adult form in two or
more distinct stages.
4. True or False: Sexual orientation and gender identity are the same thing.
5. What percentage of transgender people do you think reported negative experiences
in the health care setting?
a. 27%
b. 33%
c. 45%
d. 66%
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6. Which population faces the most bias and discrimination?
a. Transgender men
b. Hispanic gay males
c. Bisexual women of color
d. Transgender women of color
7. According to the CDC, what is the HIV prevalence for transgender women?
a. 3.3%
b. 14.1%
c. 35.8%
d. 40.2%
8. What ratio of transgender women have HIV?
a. 3 in 10 transgender women
b. 4 in 10 transgender women
c. 7 in 10 transgender women
d. 6 in 10 transgender women
9. What percentage of black transgender women do you think have HIV?
a. 28%
b. 36%
c. 53%
d. 62%
10. What percentage of HIV diagnosis did the transgender community received by
mode of HIV exposure?
a. 1%
b. 3.3%
c. 5.5%
d. 8%
11. What is the main interpersonal variable that is making the transgender community
vulnerable to HIV?
a. Sexual assault
b. Physical violence
c. Lack of social support
12. Which structural and social determinant has the highest percentage in putting
pressure on the transgender community?
a. Discrimination
b. Unemployment
c. Homelessness

88
13. Select all that apply: What information should be added to the electronic health
record system for someone that does not identify with their birth sex?
a. Pronouns
b. Gender dysphoria
c. Mental illness
d. Gender identity
e. Preferred name
14. True or False: Try to avoid using gender terms or pronoun with new patient until
this information is known whether in person or over the phone.
15. Which statement should be use when asking a transgender patient how they would
like to be addressed?
a. Excuse me, what is your prefer pronoun?
b. Mr. Williams, do you identify as he/him or she/her?
c. Your photo ID does not match your appearance; is there a reason as to why it does
not?
d. I would like to be respectful. What name and pronouns would you like me to use?

